A Study of Prevalence of HPV and Determinants of Poor Outcomes of HIV Positive and Negative Patients with Oropharyngeal Cancers in Botswana

Kathryn Anastos

HIV/HPV Cancer Prevention, Treatment & Pathogenesis: Rwanda/Einstein Consortium

Other pharynx Lip, oral cavity

Pathology

Nathaniel Rothman

Studies in the Janus Cohort

Lip, oral cavity

Pathology

Nathaniel Rothman

DDT, PCBs, and Other Persistent Organohalide Chemicals in the JANUS Cohort

Lip, oral cavity

Pathology

Philip C Trackman

Cellular or Extracellular Targeting of Lysyl Oxidase Propeptide for Oral Cancer

Lip, oral cavity

Harold M Swartz

Direct and Repeated Clinical Measurement of pO2 for Enhancing Cancer Therapy

Other pharynx Non-Hodgkin lymphoma Cervix uteri Breast Brain, nervous system

Radiation Oncology

Robert W. Coombs

Laboratory Center, AIDS Clinical Trials Group (ACTG); LC 2 / 3

Trachea, bronchus and lung Other pharynx Oesophagus Non-Hodgkin lymphoma Nasopharynx Liver and intrahepatic bile ducts Kidney, renal pelvis and ureter Kaposi sarcoma Hodgkin lymphoma Colorectum Cervix uteri

David Sidransky

Head and Neck Cancer SPORE

Other pharynx

Pathology

Peter S Hammerman

Therapeutic targeting of Fibroblast Growth Factor Receptors in Squamous Cancers

Trachea, bronchus and lung Other pharynx Oesophagus Nasopharynx Lip, oral cavity Larynx

Belinda Nicolau

CRC Tier 2 - Chronic oral disease (COD) aetiology

Other pharynx Oesophagus Nasopharynx Lip, oral cavity Larynx

Pediatric oncology or childhood cancer